Foundery Launches Inaugural Biotech Venture Creation Fund to Accelerate the Development of Novel Immunotherapies SAN FRANCISCO, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Foundery, a biotechnology venture studio focused on translating immunology discoveries into drug candidates, today announced an initial closing of...

Foundery and the University of Arizona Sign Master Agreement to Translate Novel Discoveries into Transformational Immunotherapies SAN FRANCISCO, April 06, 2023 (GLOBE NEWSWIRE) -- Foundery, a biotechnology venture studio focused on translating immunology discoveries into drug candidates, has entered into a master agreement...

Foundery Innovations Establishes Scientific Advisory Board with Appointment of Key Opinion Leaders in Immunology and Oncology SAN FRANCISCO, March 28, 2023 (GLOBE NEWSWIRE) -- Foundery Innovations (“Foundery”), a biotechnology venture studio focused on translating immunology discoveries into drug candidates, announced the...

Foundery Innovations Adds to Executive and Scientific Teams with Two Key Appointments Jate Samathivathanachai, MBA, CLP, as Chief Business OfficerVladi Juric, Ph.D., as Senior Director and Head of Pharmacology SAN FRANCISCO, March 01, 2023 (GLOBE NEWSWIRE) -- Foundery Innovations...

The University of California and Foundery Sign Master Agreement to Translate Novel Discoveries into Transformational Immunotherapies SAN FRANCISCO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The University of California, San Francisco (“UCSF”) and Foundery, a biotechnology venture studio focused on translating immunology discoveries into...